|
| 36404465 | Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program. | Ann Epidemiol | 2023 |
| 37738239 | Large-scale whole exome sequencing studies identify two genes,CTSL and APOE, associated with lung cancer. | PLoS Genet | 2023 |
| 37369027 | Circulating proteome for pulmonary nodule malignancy. | J Natl Cancer Inst | 2023 |
| 36694401 | A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers. | Int J Cancer | 2023 |
| 35773316 | Deciphering associations between three RNA splicing-related genetic variants and lung cancer risk. | NPJ Precis Oncol | 2022 |
| 33472890 | Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model. | Cancer Res | 2021 |
| 34642315 | Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer. | Nat Commun | 2021 |
| 32393777 | Protein-altering germline mutations implicate novel genes related to lung cancer development. | Nat Commun | 2020 |
| 32699080 | Genetic Determinants of Lung Cancer Prognosis in Never Smokers: A Pooled Analysis in the International Lung Cancer Consortium. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 30700444 | Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis. | Cancer Epidemiol Biomarkers Prev | 2019 |
| 31665182 | Correction:Â Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma. | PLoS One | 2019 |
| 31263055 | Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer. | Cancer Epidemiol Biomarkers Prev | 2019 |
| 30590402 | Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci. | Carcinogenesis | 2019 |
| 28892201 | Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma. | Mol Carcinog | 2018 |
| 30104567 | Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. | Nat Commun | 2018 |
| 29924316 | Genome-wide association study of familial lung cancer. | Carcinogenesis | 2018 |
| 29715275 | Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma. | PLoS One | 2018 |
| 29071797 | Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer. | Mol Carcinog | 2018 |
| 27827316 | BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial. | Clin Cancer Res | 2017 |
| 28304396 | Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. | Sci Rep | 2017 |
| 28383684 | Functional variants in DCAF4 associated with lung cancer risk in European populations. | Carcinogenesis | 2017 |
| 28400551 | Genetic variants of PTPN2 are associated with lung cancer risk: a re-analysis of eight GWASs in the TRICL-ILCCO consortium. | Sci Rep | 2017 |
| 28150878 | Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus. | Mol Carcinog | 2017 |
| 28604730 | Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. | Nat Genet | 2017 |
| 27805284 | Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk-A re-analysis of eight GWASs. | Mol Carcinog | 2017 |
| 26816351 | ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients. | Cancer Epidemiol | 2016 |
| 26637267 | A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer. | Cancer Epidemiol Biomarkers Prev | 2016 |
| 27713484 | A Novel Genetic Variant in Long Non-coding RNA Gene NEXN-AS1 is Associated with Risk of Lung Cancer. | Sci Rep | 2016 |
| 26905588 | Polymorphisms of the centrosomal gene (FGFR1OP) and lung cancer risk: a meta-analysis of 14,463 cases and 44,188 controls. | Carcinogenesis | 2016 |
| 24947688 | Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium. | Int J Cancer | 2015 |
| 26363033 | Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. | Carcinogenesis | 2015 |
| 26483192 | Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions. | Hum Mol Genet | 2015 |
| 26319099 | Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer. | J Natl Cancer Inst | 2015 |
| 25633805 | Cancer patients' acceptability of incorporating an epidemiology questionnaire within a clinical trial. | Clin Trials | 2015 |
| 25519392 | Haplotype approach for association analysis on hypertension. | BMC Proc | 2014 |
| 25519401 | Genetic association analysis for common variants in the Genetic Analysis Workshop 18 data: a Dirichlet regression approach. | BMC Proc | 2014 |